Authorship

George A. Wells; Jesse Elliott; Shannon Kelly; Zemin Bai; Michel Boucher; Becky Skidmore; Derek So; Suzanne Laplante; Karen Lee

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Wells GA, Elliott J, Kelly S, et al. Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Mar. (CADTH Optimal Use Report, No. 9.2b.)

Cover of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration

Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration [Internet].

Show details

Contents

< Prev Next >

Authorship

Clinical Evaluation

George A. Wells, PhD, Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, Ottawa, Ontario.

Jesse Elliott, MSc, PhD(c), Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, Ottawa, Ontario.

Shannon Kelly, MSc, PhD(c), Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, Ottawa, Ontario.

Zemin Bai, MD, MSc, Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, Ottawa, Ontario.

Michel Boucher, BPharm, MSc, CADTH, Ottawa, Ontario.

Becky Skidmore, MLS, Independent Information Specialist, Ottawa, Ontario.

Derek So, MD, FRCPC, FACC, MSc, Staff Cardiologist and Clinician Investigator, University of Ottawa Heart Institute; Associate Professor, Department of Medicine, University of Ottawa Faculty of Medicine, Ottawa, Ontario.

Economic Evaluation

Suzanne Laplante, BPharm, MSc, DLSHTM, CADTH, Ottawa, Ontario.

Karen Lee, BA, MA, CADTH, Ottawa, Ontario.

The copyright and other intellectual property rights in this document are owned by CADTH and its licensors. These rights are protected by the Canadian Copyright Act and other national and international laws and agreements. Users are permitted to make copies of this document for non-commercial purposes only, provided it is not modified when reproduced and appropriate credit is given to CADTH and its licensors.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK542933

Contents

< Prev Next >

PubReader
Print View
Cite this Page
Wells GA, Elliott J, Kelly S, et al. Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Mar. (CADTH Optimal Use Report, No. 9.2b.) Authorship.
PDF version of this title (1.7M)

Authorship - Dual Antiplatelet Therapy Following Percutaneous Coronary Intervent...
Authorship - Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Bookshelf

Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration [Internet].

Authorship

Clinical Evaluation

Economic Evaluation

Views

In this Page

Other titles in this collection

Recent Activity